Default company panoramic image

AdeTherapeutics Inc

Our patented products address complications related to surgery and ageing and set standard of care for clinicians, hospitals and patients.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Canada
  • Currency USD
  • Founded November 2006
  • Employees 5
  • Website

Company Summary

Our world class scientific team and leading global partners translate over 30 international held patents (IP) to develop standard of care drugs and medical devices in various surgical specialties. The products are administered during surgery and prevent conditions, such as fibrosis or scar tissue, that are responsible for 1 in3 re-admissions into hospitals and numerous complications for the patient. We sell/license our IP to biotech or pharma.


  • Default avatar
    Lynne Roberston
    EVP Regulatory Affairs & Clinical Development

    25 years of pharmaceutical experience

    MS, PhD (Pharmacology)
    EVP Regulatory Affairs, AdeTherapeutics inc (25 years plus experience)
    Director of Regulatory Affairs, Quintiles
    Vice President Operations, Norstrum Pharmaceuticals
    Director Project Management, KOS Pharmaceuticals
    Senior Director of Business and Product Development, Schering-Plough
    Project Manager, Mylan Technologies

  • Default avatar
    Sanj Singh
    President & CEO

    Co-founder and has led AdeTherapeutics Inc. from inception; attracted world class team and built key strategic partnerships with multi-national companies, raised capital to bring an idea from university labs into Phase II and expanded IP portfolio to include additional opportunities.
    Entrepreneurial start-up experience ;
    Vice-Chair of the Emerging Companies Advisory Board, BioteCanada, Ottawa, ON


  • Default avatar
    WMCZ, Mark Dolan and Craig Zwada
    Default avatar
    Deloitte, Blair Knippel, Humphrey Tam
    Default avatar
    Jennifer Fox, BS, MS, JD
    IP Counsel

Previous Investors

  • Default avatar
    AgWest Commercialization Fund
    Default avatar
    Group of private investors-names available upon request